SynBioBeta

Are you ready to join the ultimate gathering of bio geeks and changemakers? 🧪 SynBioBeta 2025 is where the synthetic biology community meets to share ideas, spark innovation, and build the future. Be part of the conversation—register today: https://loom.ly/gM9JE9M #SynBioBeta2025 #SyntheticBiology

Breakthrough in Bird Flu Prevention A new vaccine developed at the University at Buffalo offers complete protection in mice against the deadly H5N1 bird flu strain — thanks to advanced nanoparticle technology. Universal vaccine strategies like this will be in the spotlight at #SynBioBeta2025, with leaders like Jacob Glanville, Dean Kamen, and Raj Panjabi driving the conversation. read full article: https://lnkd.in/gZtVq6mT #SynBioBeta #BirdFlu #VaccineInnovation #UniversalVaccines

Can Building Materials Be Alive? Imagine walls that can heal themselves - not sci-fi, but real science happening right now in a Montana lab. Researchers at Montana State University-Bozeman have developed a living biomaterial made from fungal mycelium and bacteria. It’s not only sustainable—it’s alive, with bone-like strength and the ability to grow and repair. read full article: https://lnkd.in/gRtnssrF #Biomaterials #SustainableArchitecture #GreenTech

🎤 𝗘𝗻𝗱𝘂𝗿𝗼 𝗵𝗼𝘀𝘁𝘀 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗹𝗲𝗮𝗱𝗲𝗿𝘀 𝗳𝗼𝗿 𝗮 𝗽𝗮𝗻𝗲𝗹 𝗮𝘁 𝗦𝘆𝗻𝗕𝗶𝗼𝗕𝗲𝘁𝗮 𝟮𝟬𝟮𝟱 🎤 We are super excited for our panel discussion at the #SynBioBeta2025 biomanufacturing scale up track. This year, leading companies discuss the industry’s recent focus on how to maximize bioprocesses at scale by targeting cell heterogeneity 🎯 We are proud that: Kristy Hawkins, CSO and co-founder, Antheia, Inc. Christian Trötschel, Scientific Lead, Novonesis and Marcel Wubbolts, CTO, Vivici will join our CSO, Peter Rugbjerg, in the panel moderated by Deepti Tanjore (Advanced Biofuels and Bioproducts Process Development Unit (ABPDU)) that blends perspectives from scaling up new bioprocesses to continued optimizations of large-scale established processes “At SynBioBeta2025 we have gathered an expert panel on the science and art of scaling bioprocesses and products to discuss the previously overlooked opportunity of cell variation. I am sure that we will hear insight and innovative approaches to targeting cell heterogeneity from these industry leaders”, says Peter Rugbjerg. Join us for #SynBioBeta2025 in San Jose on May 7 at 3:30 pm to learn more about targeting heterogeneity in bioprocesses for unleashing the full potential of your process. #SynBio #Biomanufacturing #bioproductionatscale #fermentation #bioprocesses #syntheticbiology

🌍 Happy Earth Day! Join us in celebrating innovation for a healthier planet. At #SynBioBeta2025, we're spotlighting the power of synthetic biology to build a better future — from sustainable materials to climate solutions. 🎉 Use promo code EARTHDAY to get $200 OFF on your registration! Get your passes: https://lnkd.in/e6rdmrBK

Waste Not, Want Not: Synthetic Biology Helps Achieve Circular Chemistry On Earth Day, We’re Asking: What If Waste Could Power the Future? As we reflect on sustainability this Earth Day, one thing is clear: solving the climate crisis will require rethinking not just how we consume, but how we manufacture. In this new SynBioBeta Insights piece, Michael Scott Long explores how synthetic biology is helping the chemicals industry close the loop—transforming waste into valuable, renewable materials through circular chemistry. 👉 Read the full article here: https://lnkd.in/dia-2PYN The piece features insights from Dr. Jo Sadler of the The University of Edinburgh, who’s pioneering one-pot systems for converting plastic waste into bio-based chemicals. It also includes perspectives from John Nicols (former Codexis CEO and Chair of the Chemicals & Materials Track at #SynBioBeta 2025) on why legacy industrial systems resist change—and how innovation can break through. Meanwhile, Yuji Suzuki, CEO of bitBiome, Inc., explains how their AI-powered enzyme discovery platform is tackling PET plastics with precision biology. While scale-up and infrastructure remain hurdles, this article outlines a vision for a smarter, greener bioeconomy—one where biology and business converge to make waste a valuable input. On a day dedicated to protecting our planet, it’s a powerful reminder that the solutions may already be growing in our fermenters. #EarthDay #SyntheticBiology #CircularEconomy #GreenChemistry #Sustainability #Bioeconomy #AIinBiotech #IndustrialBiotech #BiotechInnovation #PlasticsRecycling

SynBioBeta embodies the belief that biology is the future—and its people who shape that future. Today, they announced the 2025 award recipients, celebrating the visionaries, innovators, and trailblazers transforming the world through synthetic biology and biotechnology. We’re thrilled to see our founder and CSO, Prof. Jason Chin, recognized among this extraordinary group. A pioneer in synthetic genomics and engineered translation, Jason is redefining what’s possible with bold ambition and groundbreaking science. We’re equally proud to celebrate our investor, Hermann Hauser, honoured with a Lifetime Achievement Award. Recognized for his visionary entrepreneurship—founding Acorn Computers and ARM Computing, cornerstones of modern computing—Hermann’s early investment in Solexa sparked the next-generation sequencing revolution through Illumina, democratising genome reading. But Hermann is equally excited about the genome writing. His strategic foresight and commitment to disruptive technologies, including championing seed-stage investment in Constructive Bio through Amadeus Capital Partners, have profoundly shaped what we do today. Congratulations to all the recipients driving the bio-revolution forward!

Lab-Grown Chicken, Upgraded 🍗 Scientists from The University of Tokyo grew thick, realistic chicken muscle using tiny straws—yes, like in a Brita filter. No more mushy meat. This one chews like the real deal. read full article: https://lnkd.in/gW8Dasks #LabGrownMeat

Congrats to all the SynBioBeta Awards winners - Jason Chin, Harshal Chokhawala, Jeanne Loring, Alexandre Zanghellini, Michael Koeris, Peter H. Diamandis, Hermann Hauser, Dean Kamen

A team of Spanish scientists has developed a groundbreaking method for delivering cell therapies to patients on ECMO - an innovation that could reshape treatment options for critical lung failure. read full article: https://lnkd.in/gh8A4QF6 #CellTherapy #LungHealth #RegenerativeMedicine